Antibody biopolymer conjugate

Abstract Antibody treatment is an emerging field of treatment. They activate the immune system and help us fight foreign matter. Antibody biopolymer conjugates (ABC) is the futuristic preparation for successfully dealing with all the drawbacks of the unconjugated naked antibodies and improving the therapeutic effect. This chapter will state detailed information from the basics about its structure, its binding, and its mechanism of action. KSI-301 is one of the most researched and important molecules of ABC that is under many clinical trials. It helps to increase patient compliance by decreasing the frequent administration of a drug and hence improving the quality of life. The chapter also includes its current application and future aspects to fascinate the reader.

[1]  D. Do,et al.  Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further? , 2022, Expert opinion on biological therapy.

[2]  C. Waeber,et al.  Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies. , 2022, Advanced drug delivery reviews.

[3]  Hudson D. Stern,et al.  KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal diseases , 2022, Expert opinion on investigational drugs.

[4]  A. Díez-Pascual.  Biopolymer Composites: Synthesis, Properties, and Applications , 2022, International journal of molecular sciences.

[5]  J. Nilvebrant,et al.  Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy , 2021, Molecules.

[6]  Chun Gwon Park,et al.  Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities , 2021, Nano Convergence.

[7]  A. Loewenstein,et al.  Next-generation anti-VEGF agents for diabetic macular oedema , 2021, Eye.

[8]  V. Sheth,et al.  New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD) , 2021, Journal of clinical medicine.

[9]  A. Agostiano,et al.  Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles , 2021, Polymers.

[10]  S. Cianférani,et al.  Non-specific interactions of antibody-oligonucleotide conjugates with living cells , 2021, Scientific Reports.

[11]  P. Seneci,et al.  Trehalose-based neuroprotective autophagy inducers. , 2021, Bioorganic & medicinal chemistry letters.

[12]  A. Mielańczyk,et al.  PDMAEMA/Polyester Miktopolymers: Synthesis via In-Out Approach, Physicochemical Characterization and Enzymatic Degradation , 2021, Materials.

[13]  S. Thirumalairajan,et al.  Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates , 2021, Journal of clinical medicine.

[14]  G. Malek,et al.  Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies , 2021, Frontiers in Cell and Developmental Biology.

[15]  V. Madanagopalan,et al.  KSI-301: antibody biopolymer conjugate in retinal disorders , 2021, Therapeutic advances in ophthalmology.

[16]  J. Szebeni,et al.  Anti-PEG antibodies: Properties, formation and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. , 2020, Advanced drug delivery reviews.

[17]  Yue Yuan,et al.  Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy. , 2020, Pharmacological research.

[18]  Iwona Grabowska-Bold,et al.  Antibody-Electroactive Probe Conjugates Based Electrochemical Immunosensors , 2020, Sensors.

[19]  Jianyou Shi,et al.  Antibodies against polyethylene glycol in human blood: A literature review. , 2020, Journal of pharmacological and toxicological methods.

[20]  T. Ciulla,et al.  Innovative therapies for neovascular age-related macular degeneration , 2019, Expert opinion on pharmacotherapy.

[21]  Vicki Sifniotis,et al.  Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation , 2019, Antibodies.

[22]  Vinita Balasubramanya.  Antibody Conjugation , 2018, Materials and Methods.

[23]  T. Ciulla,et al.  Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy , 2016, Expert opinion on biological therapy.

[24]  Xiaohui Wang,et al.  Simple Method To Prepare Oligonucleotide-Conjugated Antibodies and Its Application in Multiplex Protein Detection in Single Cells. , 2016, Bioconjugate chemistry.

[25]  A. Pandit,et al.  Polymer-antibody fragment conjugates for biomedical applications , 2014 .

[26]  Xinyu Zhao,et al.  Several Affinity Tags Commonly Used in Chromatographic Purification , 2013, Journal of analytical methods in chemistry.

[27]  P. Baran,et al.  Bioconjugation by native chemical tagging of C-H bonds. , 2013, Journal of the American Chemical Society.

[28]  Paul W. H. I. Parren,et al.  Therapeutic antibody engineering , 2013, mAbs.

[29]  Cornelia G Palivan,et al.  Stimuli-Responsive Polymers and Their Applications in Nanomedicine , 2012, Biointerphases.

[30]  Hamidreza Ghandehari,et al.  Polymeric conjugates for drug delivery. , 2012, Chemistry of materials : a publication of the American Chemical Society.

[31]  F. Jacobsen,et al.  Development of a novel mammalian cell surface antibody display platform , 2010, mAbs.

[32]  Jason E Hein,et al.  Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides. , 2010, Chemical Society reviews.

[33]  Ashim K. Mitra,et al.  Recent Perspectives in Ocular Drug Delivery , 2009, Pharmaceutical Research.

[34]  M. Bartoli,et al.  Vascular endothelial growth factor in eye disease , 2008, Progress in Retinal and Eye Research.

[35]  R. Kim.  Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration , 2007, Indian journal of ophthalmology.

[36]  R. Minter,et al.  Harnessing phage and ribosome display for antibody optimisation. , 2006, Trends in biotechnology.

[37]  Kazuhiko Ishihara,et al.  Phosphorylcholine-containing polymers for biomedical applications , 2005, Analytical and bioanalytical chemistry.

[38]  M. Chee,et al.  Efficient strategies for the conjugation of oligonucleotides to antibodies enabling highly sensitive protein detection. , 2004, Biopolymers.

[39]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[40]  V. Shankar,et al.  Therapeutic Applications of Monoclonal Antibodies , 2002, The American Journal of the Medical Sciences.

[41]  C. Barbas,et al.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Vallet,et al.  [Hydroxyethyl starch]. , 2010, Annales Francaise d'Anesthesie et de Reanimation.